Objective: To describe blood pressures, and hypertension and its management among older people.
Design: Two combined annual cross-sectional surveys.
Setting: England 2000 and 2001.
Participants: Nationally-representative sample of 3513 non-institutionalized people aged more than 64 years (elderly).
Main Outcome Measures: (1). Use of antihypertensive agents, and hypertension according to two definitions: receiving blood pressure decreasing treatment, or either: systolic blood pressure > or= 160 mmHg or diastolic blood pressure > or= 90 mmHg (old); or systolic blood pressure > or= 140 mmHg or diastolic blood pressure > or=90 mmHg (new). (2). Rates of treatment and control (old: < 160/90 mmHg; new: < 140/85 mmHg). (3). Isolated systolic hypertension stage 1 (systolic blood pressure > or= 140-159 mmHg and diastolic blood pressure < 90 mmHg), or stage 2 (systolic blood pressure > or= 160 mmHg and diastolic blood pressure < 90 mmHg).
Results: In 2000/2001, 62 and 81% of elderly adults were hypertensive according to the old and new definitions, respectively. Among those with hypertension (new definition) treatment and control rates were 56 and 19% (control rates among those treated were 36% in men and 30% in women). Of those treated, 54% were receiving one drug, 35% were receiving two, and 10% were receiving three or more drugs. Among untreated hypertensive individuals, 23% had increased systolic and diastolic pressures, 76% had isolated systolic hypertension and 1% had isolated diastolic hypertension.
Conclusions: These data suggest that, according to current guidelines more than 67% of older English adults should receive antihypertensive medication. To pre-empt this situation, population-based strategies to reduce the current rate of increase in blood pressure throughout adult life should be urgently implemented. Only then will the current epidemic of hypertension among the elderly, with the huge cost associated with its management and adverse cardiovascular sequelae, be averted.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00004872-200406000-00008 | DOI Listing |
Nephrol Nurs J
January 2025
Professor of Pharmacy Practice, Clinical Pharmacotherapy Specialist, Nephrology & Dialysis, Arnold &Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY.
Intradialytic hypotension (IDH) is a common occurrence in hemodialysis. IDH occurs when there is a drop in blood pressure along with hypotensive symptoms. There are various causes of IDH, and it is important to consider proper management of this condition.
View Article and Find Full Text PDFNephrol Nurs J
January 2025
Professor of Medicine, Department of Internal Medicine, Division of Nephrology, School of Medicine, Virginia Commonwealth University.
Chronic kidney disease (CKD) affects 10% of the global population, with increasing prevalence driven by diabetes, hypertension, and aging populations. CKD often progresses asymptomatically, frequently undetected until advanced stages, and may require costly treatments, such as dialysis or transplantation. CKD imposes a substantial financial burden on health care systems, with management costs rising sharply as the disease progresses, underscoring the need for early, cost-effective interventions.
View Article and Find Full Text PDFArtif Organs
January 2025
Department of Nephrology, Faculty of Medicine, Dokuz Eylul University, Izmir, Türkiye.
Introduction: Removing uremic toxins from the body is one of the most critical points in the maintenance hemodialysis (MHD) population. This study aimed to evaluate the effects of medium cutoff (MCO) membranes on pulse wave velocity (PWV) and augmentation index (AIx), early markers of arterial stiffness, in MHD patients over both short- and long-term periods.
Methods: Twenty MHD patients were included in this study.
Elife
January 2025
Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Estrogen significantly impacts women's health, and postmenopausal hypertension is a common issue characterized by blood pressure fluctuations. Current control strategies for this condition are limited in efficacy, necessitating further research into the underlying mechanisms. Although metabolomics has been applied to study various diseases, its use in understanding postmenopausal hypertension is scarce.
View Article and Find Full Text PDFJ Am Heart Assoc
January 2025
Department of Population Health Sciences Weill Cornell Medicine New York NY.
Background: Transport by mobile stroke units (MSUs), which provide access to computed tomography scanning and intravenous blood pressure medications and thrombolytics, reduces time to treatment and may improve short-term functional outcomes for patients with acute stroke. The longer-term clinical and financial impacts remain incompletely understood. The aim of the study was to determine whether MSU care is associated with better health, utilization, and spending outcomes for patients with suspected acute stroke.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!